Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock

Soni Savai Pullamsetti1, Daniel Maring, Hossein Ardeschir Ghofrani

  • 1Departmennt of Internal Medicine, Justus-Liebig-University Giessen, Klinikstrasse 36, 35392 Giessen, Germany.

Insights

Selective inducible nitric oxide synthase (iNOS) inhibitors effectively treat septic shock by improving hemodynamics and microcirculation, outperforming non-selective inhibitors and norepinephrine in a rat model.

Area of Science:

  • Physiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Septic shock causes hemodynamic instability and microcirculatory dysfunction.
  • Vasopressors can worsen microcirculation, while nitric oxide synthase (NOS) inhibition is a potential alternative.
  • Excessive nitric oxide (NO) production is implicated in sepsis pathophysiology.

Purpose of the Study:

  • To compare the effects of norepinephrine, non-selective NOS inhibition (L-NMMA), and selective inducible NOS (iNOS) inhibition (1400W) on hemodynamics and microcirculation in endotoxic shock.
  • To evaluate therapeutic strategies for managing macro- and microcirculatory abnormalities in experimental septic shock.

Main Methods:

  • Male Wistar rats received endotoxin (LPS) or saline, followed by randomization to saline, norepinephrine, L-NMMA, or 1400W treatment.
  • Hemodynamic parameters (blood pressure) and tissue oxygenation (ileum mucosal layer using EMPHO) were measured.
  • Lactate levels and plasmatic nitrite/nitrate concentrations were analyzed.

Main Results:

  • LPS-induced shock resulted in hypotension, acidosis, and increased nitrite/nitrate levels.
  • Norepinephrine stabilized blood pressure but worsened lactate acidosis and microcirculatory oxygenation.
  • Selective iNOS inhibition with 1400W improved blood pressure, reduced nitrite/nitrate, and preserved microcirculatory oxygenation without exacerbating acidosis.

Conclusions:

  • Selective iNOS inhibitors, like 1400W, are superior to non-specific NOS inhibitors and norepinephrine in treating experimental septic shock.
  • Targeting iNOS offers a promising therapeutic approach for improving both macro- and microcirculatory function in septic shock.
  • Selective iNOS inhibition mitigates detrimental effects on microcirculation often seen with conventional vasopressor therapy.